INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 285 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,712,048 | +79.5% | 370,400 | +131.5% | 0.05% | -2.1% |
| Q2 2023 | $6,524,800 | -56.2% | 160,000 | -60.0% | 0.05% | -27.7% |
| Q1 2023 | $14,908,000 | +105.3% | 400,000 | +92.2% | 0.06% | -12.2% |
| Q4 2022 | $7,260,609 | +765.4% | 208,100 | +1287.3% | 0.07% | +957.1% |
| Q3 2022 | $839,000 | -76.9% | 15,000 | -78.7% | 0.01% | -75.0% |
| Q2 2022 | $3,639,000 | -22.2% | 70,300 | +9.2% | 0.03% | -55.6% |
| Q1 2022 | $4,680,000 | +31.9% | 64,400 | +114.7% | 0.06% | +75.0% |
| Q4 2021 | $3,547,000 | +51.1% | 30,000 | +71.4% | 0.04% | +12.5% |
| Q3 2021 | $2,348,000 | – | 17,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |